Skip to main content

Published locations for Cutaneous erythema predicted low-dose alemtuzumab response in leukemic cutaneous T-cell lymphoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Cutaneous erythema predicted low-dose alemtuzumab response in leukemic cutaneous T-cell lymphoma

User login

  • Reset your password
  • /content/cutaneous-erythema-predicted-low-dose-alemtuzumab-response-leukemic-cutaneous-t-cell
  • /familypracticenews/article/81838/dermatology/cutaneous-erythema-predicted-low-dose-alemtuzumab
  • /hematologynews/article/81838/dermatology/cutaneous-erythema-predicted-low-dose-alemtuzumab-response
  • /internalmedicinenews/article/81838/dermatology/cutaneous-erythema-predicted-low-dose-alemtuzumab
  • /hematology-oncology/article/81838/dermatology/cutaneous-erythema-predicted-low-dose-alemtuzumab
  • /internalmedicine/article/81838/dermatology/cutaneous-erythema-predicted-low-dose-alemtuzumab
  • /familymedicine/article/81838/dermatology/cutaneous-erythema-predicted-low-dose-alemtuzumab-response